Form 10-Q SKYSTAR BIO-PHARMACEUTIC For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500, Nasdaq set for higher open as investors weigh weaker oil, PPI data
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Birkenstock surges on revenue beat, higher full-year outlook
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Skystar Bio-Pharma (SKBI) Reports Q2 EPS of $0.37
August 15, 2014 7:37 AM EDTSkystar Bio-Pharma (NASDAQ: SKBI) reported Q2 EPS of $0.37, versus $0.49 reported last year. Revenue for the quarter came in at $14.2 million, versus $11.3 million reported last year.
For earnings history and earnings-related data on Skystar Bio-Pharma (SKBI) click here.
... More